Scott B. Ullem - 21 Feb 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Chief Financial Officer
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 21 Feb 2022
Transactions value $: -$33,693
Form type: 4
Filing time: 22 Feb 2022, 17:36:47 UTC
Previous filing: 30 Nov 2021
Next filing: 05 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	-$33,692	-319	-0.86%	$105.62	36,812	21 Feb 2022	Direct
holding	EW	Common Stock						229,251	21 Feb 2022	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.